TITLE

human papillomavirus, vaccines and cervical cancer prevention

AUTHOR(S)
Cadman, Louise
PUB. DATE
November 2006
SOURCE
Learning Disability Practice;Nov2006, Vol. 9 Issue 9, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the development of a prophylactic vaccine for prevention of papillomavirus and cervical cancer that would likely exist to women in Great Britain. The occurrence of such diseases have been recognized by health professionals to exist mostly in women with disabilities because this group has the smallest percentage of have undergone cervical smear test. The vaccine were developed to prevent infection of people with papillomavirus.
ACCESSION #
23139162

 

Related Articles

  • HPV vaccine Beyond the hype.  // Consumer Reports;Oct2007, Vol. 72 Issue 10, p47 

    This article discusses the Human Papillomavirus (HPV) vaccine Gardasil and its promise to protect women against four dangerous strains of the virus that causes most cases of cervical cancer and genital warts. Gardasil's manufacturer, Merck, has lobbied to make the vaccine mandatory, and at least...

  • It will save lives, particularly among the most vulnerable. Lynch, Jo-Ann // American Teacher;May/Jun2007, Vol. 91 Issue 7, p4 

    The author points out that being vaccinated against the human papillomavirus (HPV) would protect many women in the U.S. from contracting cervical cancer. The article also states that the many people who do not have health insurance and avoid medical care would be helped by the vaccine. The...

  • Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Schwartz, J. L.; Caplan, A. L.; Faden, R. R.; Sugarman, J. // Clinical Pharmacology & Therapeutics;Dec2007, Vol. 82 Issue 6, p760 

    The licensure in 2006 of a vaccine against the subtypes of human papillomavirus (HPV) responsible for the majority of cervical cancers and genital warts was heralded as a watershed moment for vaccination, cancer prevention, and global health.1 A safe and effective vaccine against HPV has long...

  • From the editors.  // Nature Reviews Cancer;Oct2006, Vol. 6 Issue 10, p743 

    The article discusses the need to immunize women, aged between 9-16 years, with the human papilloma virus (HPV) vaccine to prevent cervical cancer. The vaccine got the approval of the U.S. Food and Drug Administration in June 2006. It is important to introduce HPV vaccines in the developing...

  • Cervical cancer prevention: vaccine for girls. Cadman, Louise // Paediatric Nursing;Dec2006, Vol. 18 Issue 10, p26 

    The article focuses on cervical cancer prevention in Great Britain and offers information on vaccines for girls. In September 2006 the first vaccine for the prevention of cervical cancer caused by oncogenic human papillomavirus (HPV) was granted a license by the European Commission. The Gardasil...

  • What Women Need To Know About HPV And Cervical Cancer. Achong, M. Natalie // Ebony;Jul2007, Vol. 62 Issue 9, p146 

    The article offers information about the human papillomavirus (HPV) vaccine. HPV refers to a group of viruses that infect genital area and cause genital cancer. The HPV vaccine could prevent viral infections caused by 70 percent of high-risk viruses. Proposal for mandatory HPV vaccination for...

  • The introduction of the human papillomavirus vaccine -- key issues. Peate, Ian // British Journal of Nursing;1/22/2009, Vol. 18 Issue 2, p86 

    The human papillomavirus (HPV) vaccine was introduced in to the national immunization programme at the beginning of the 2008/2009 school year, being offered routinely to all 12--13-year-old girls with the aim of protecting them against cervical cancer. There are two particularly high risk HPV...

  • January is Cervical Cancer awareness month.  // Tennessee Tribune;1/20/2011, Vol. 22 Issue 3, p6B 

    The article offers information on the preventive measures for protection, symptoms, and risk factors of cervical cancer which is mostly acquired by women because of human papilloma virus infection.

  • Response to The HPV Vaccination Campaign: A Project of Moral Regulation in an Era of Biopolitics. MACDONALD, LIANE; DEEKS, SHELLEY; DOYLE, CAROLYN // Canadian Journal of Sociology;Fall2010, Vol. 35 Issue 4, p627 

    In this article the authors discuss the Canadian public health campaign regarding the human papillomavirus (HPV) vaccination used for the prevention of cervical cancer. They argue that a voluntary program in schools could provide access to the HPV vaccination for low-income and Aboriginal women,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics